Dinsmoor announces retirement at Nebraska Medicine









picture disc.

Bill Dinsmoor

Bill Dinsmoor, who has been serving as interim CEO since Nov. 2013, announced Tuesday that he will retire.

Nebraska Medicine board leaders also announced they will conduct a national search for the next chief executive officer.

“This organization is transforming lives and attracting the engagement and goodwill of our local community, the region and the world,” said UNMC Chancellor and Nebraska Medicine advisory board chair Jeffrey P. Gold, M.D. “Our economic impact associated with education, research and patient care exceeds $4 billion annually. We’re making history here and are very excited to announce our intent to conduct an exhaustive nationwide search for the chief executive officer.”

“A tremendous amount of progress has been made in our first year at Nebraska Medicine,” Dinsmoor said. “We’ve successfully unified the culture, transformed our operations and integrated our patient care delivery. Nebraska Medicine is well positioned for the future and I’m proud of the entire organization’s commitment and courage to prepare for the next generation of health care.”

Dr. Britigan to continue
as interim president

Nebraska Medicine’s interim president and CEO roles have been held by two leaders — Bradley Britigan, M.D. as interim president and Dinsmoor as interim CEO. As the national search for a permanent CEO commences, Dr. Britigan will remain in his role as Nebraska Medicine’s interim president. Dr. Britigan also serves as the dean of UNMC’s College of Medicine.

“Bill Dinsmoor has served the organization for over 30 years, with most of those years in the role of chief financial officer,” Dr. Gold said. “Over the last year, his efforts to restructure and transform the clinical operations of the organization have been critical for our success. He and I have worked together to unify the culture, and position the organization for this next transition in leadership.”

Dinsmoor said, “In preparation for retirement, I believe the timing is right to focus on the search for our CEO, a leader who will leverage our momentum and extraordinary strengths — to take the organization to the next level.”

It’s been a year of record growth and transformation. Expansion of the organization continues in a number of areas, including emergency, observation and inpatient rooms at Nebraska Medical Center, the $323 million Fred & Pamela Buffett Cancer Center scheduled to open in 2017, the $70 million Lauritzen Outpatient Center to open in late 2016, and a significant expansion of ambulatory services at Nebraska Medicine’s Village Pointe campus.

“All of our colleagues at Nebraska Medicine have stepped up to meet historic levels of demand for the wide array of services we provide,” Dr. Gold said. “There’s a growing momentum, energy and vibrancy that can be felt throughout our hospitals and clinics, and it’s clear that we will extend the reach of our mission far beyond what would be possible as separate organizations. I have complete confidence in Nebraska Medicine’s future.”

1 comment

  1. Janet Smith says:

    Congratulations! A job well done. Best wishes for a great time in retirement!

Comments are closed.